Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kewaunee Scientific (KEQU) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $2.9 million.

  • Kewaunee Scientific's Shares Outstanding (Weighted Average) fell 20.89% to $2.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $2.9 million, marking a year-over-year decrease of 20.89%. This contributed to the annual value of $2.9 million for FY2025, which is 59.05% down from last year.
  • Kewaunee Scientific's Shares Outstanding (Weighted Average) amounted to $2.9 million in Q4 2025, which was down 20.89% from $2.9 million recorded in Q3 2025.
  • Kewaunee Scientific's 5-year Shares Outstanding (Weighted Average) high stood at $2.9 million for Q4 2023, and its period low was $2.8 million during Q2 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $2.8 million (2022), whereas its average is $2.8 million.
  • Per our database at Business Quant, Kewaunee Scientific's Shares Outstanding (Weighted Average) surged by 257.95% in 2023 and then crashed by 106.79% in 2024.
  • Kewaunee Scientific's Shares Outstanding (Weighted Average) (Quarter) stood at $2.8 million in 2021, then grew by 1.47% to $2.8 million in 2022, then rose by 2.58% to $2.9 million in 2023, then decreased by 1.07% to $2.9 million in 2024, then fell by 0.21% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q4 2025, $2.9 million for Q3 2025, and $2.9 million during Q2 2025.